title: Inhibition of long-chain acyl coenzyme A synthetases during fatty acid loading induces lipotoxicity in macrophages.
abstract: OBJECTIVE
  Obesity is often associated with hypertriglyceridemia and elevated free fatty acids (FFAs), which are independent risk factors for cardiovascular disease and diabetes. Although impairment of cholesterol homeostasis is known to induce toxicity in macrophages, the consequence of altered fatty acid homeostasis is not clear.
  
  
  RESULTS
  Long-chain acyl CoA synthetases (ACSLs) play a critical role in fatty acid homeostasis by channeling fatty acids to diverse metabolic pools. We treated mouse peritoneal macrophages (MPMs) with VLDL or FFAs in the presence of triacsin C, an inhibitor of the 3 ACSL isoforms present in macrophages. Treatment of macrophages with VLDL and triacsin C resulted in reduced TG accumulation but increased intracellular FFA levels, which induced lipotoxicity characterized by apoptosis. Treatment of MPMs with the saturated fatty acid stearic acid in the presence of triacsin C increased intracellular stearic acid and induced apoptosis. Stromal vascular cells collected from high-fat diet-fed mice displayed foam cell morphology and exhibited increased mRNA levels of macrophage markers and ACSL1. Importantly, all of these changes were associated with increased FFA level in AT.
  
  
  CONCLUSIONS
  Inhibition of ACSLs during fatty acid loading results in apoptosis via accumulation of FFAs. Our data have implications in understanding the consequences of dysregulated fatty acid metabolism in macrophages.
authors.affiliation: Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37232-0615, USA.
authors.forename: Viswanathan
authors.initials: V
authors.lastname: Saraswathi
authors.forename: Alyssa H
authors.initials: AH
authors.lastname: Hasty
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002470:Cell Survival; D002478:Cells, Cultured; D015243:Cholesterol, VLDL / Q000378:metabolism / Q000494:pharmacology; D003066:Coenzyme A Ligases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism* / Q000494:pharmacology; D050356:Lipid Metabolism / Q000187:drug effects / Q000502:physiology*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D012680:Sensitivity and Specificity; D014226:Triazenes / Q000494:pharmacology
chemical_list: D015243:Cholesterol, VLDL; D005230:Fatty Acids, Nonesterified; D014226:Triazenes; C034613:triacsin C; D003066:Coenzyme A Ligases
references.citation: Atherosclerosis. 2005 Jun;180(2):233-44
references.pmid: 15910848
references.citation: Biochemistry. 2005 Feb 8;44(5):1635-42
references.pmid: 15683247
references.citation: Arterioscler Thromb. 1992 Dec;12(12):1458-66
references.pmid: 1450177
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82
references.pmid: 12629214
references.citation: J Biol Chem. 2008 Jan 25;283(4):1773-7
references.pmid: 18024425
references.citation: J Clin Invest. 1982 Jul;70(1):168-78
references.pmid: 6282937
references.citation: Am J Med. 2007 Mar;120(3 Suppl 1):S3-S11
references.pmid: 17320520
references.citation: Curr Opin Lipidol. 2003 Jun;14(3):281-7
references.pmid: 12840659
references.citation: J Lipid Res. 1993 May;34(5):703-17
references.pmid: 8509711
references.citation: J Biol Chem. 2001 Jul 6;276(27):24667-73
references.pmid: 11319222
references.citation: J Clin Invest. 2003 Dec;112(12):1796-808
references.pmid: 14679176
references.citation: Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):146-52
references.pmid: 19171470
references.citation: Diabetes. 2007 Apr;56(4):1143-52
references.pmid: 17259370
references.citation: Diabetes Metab Res Rev. 2002 Mar-Apr;18 Suppl 2:S5-9
references.pmid: 11921432
references.citation: Am J Med. 2007 Feb;120(2 Suppl 1):S3-8; discussion S29-32
references.pmid: 17296343
references.citation: J Lipid Res. 2004 May;45(5):972-80
references.pmid: 14967823
references.citation: J Clin Invest. 2003 Dec;112(12):1821-30
references.pmid: 14679177
references.citation: J Lipid Res. 2004 May;45(5):794-804
references.pmid: 14993245
references.citation: Annu Rev Nutr. 1989;9:253-70
references.pmid: 2669873
references.citation: Arteriosclerosis. 1984 Mar-Apr;4(2):103-14
references.pmid: 6704048
references.citation: Am J Clin Nutr. 2000 Jan;71(1):81-7
references.pmid: 10617950
references.citation: J Lipid Res. 2004 Oct;45(10):1958-61
references.pmid: 15292367
references.citation: J Biol Chem. 2006 Jan 13;281(2):945-50
references.pmid: 16263710
references.citation: Horm Metab Res. 2007 Oct;39(10):722-5
references.pmid: 17952833
references.citation: J Biol Chem. 2007 Nov 30;282(48):35279-92
references.pmid: 17916553
references.citation: Am J Physiol Endocrinol Metab. 2006 Oct;291(4):E737-44
references.pmid: 16705061
references.citation: J Lipid Res. 2006 Jul;47(7):1406-15
references.pmid: 16639077
references.citation: J Biol Chem. 2003 Oct 31;278(44):43008-13
references.pmid: 12937175
references.citation: J Biol Chem. 2000 Aug 4;275(31):23807-13
references.pmid: 10791964